You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent childhood giant cell glioblastoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib

Terminated
Has Results
  • Childhood Choroid Plexus Tumor
  • +18 more
  • palbociclib isethionate
  • +2 more
  • Los Angeles, California
  • +10 more
Feb 10, 2021

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

Active, not recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • Radiation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

Recruiting
  • Recurrent Glioblastoma Multiforme
  • SNC-109 CAR-T Cells
  • Beijing, China
    Chinese PLA General Hospital
May 11, 2023

Recurrent Glioblastoma Trial in Beijing (Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous

Not yet recruiting
  • Recurrent Glioblastoma
  • Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Oct 10, 2022

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023

Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

Not yet recruiting
  • Neoplasms
  • +7 more
  • Biological G207
  • Birmingham, Alabama
    Children's of Alabama
Jun 1, 2022

Glioblastoma, Recurrent Disease, Recurrent Glioblastoma Trial in Calgary (Afatinib, Dasatinib, Palbociclib)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Jun 24, 2022

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

    Not yet recruiting
    • Glioblastoma Multiforme of Brain
    • CHM-1101 CAR-T cells
    • Duarte, California
      City of Hope Medical Center
    Dec 19, 2022

    Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

    Active, not recruiting
    • Childhood Astrocytoma
    • +9 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 8, 2022

    Recurrent Glioblastoma Trial in Los Angeles (Activated T cells)

    Not yet recruiting
    • Recurrent Glioblastoma
    • Activated T cells
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Apr 21, 2022

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)

      Completed
      Has Results
      • Adult Giant Cell Glioblastoma
      • +3 more
      • bevacizumab
      • radiation therapy
      • Birmingham, Alabama
      • +30 more
      Dec 27, 2022

      Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

      Withdrawn
      • Recurrent Anaplastic Astrocytoma
      • +7 more
      • Neural Stem Cells-expressing CRAd-S-pk7
      • Resection
      • (no location specified)
      Nov 22, 2022

      Glioblastoma Multiform, Recurrent Glioblastoma Trial in Tehran (NK cell therapy)

      Recruiting
      • Glioblastoma Multiform
      • Recurrent Glioblastoma
      • NK cell therapy
      • Tehran, Iran, Islamic Republic of
        Royan institute
      Nov 13, 2021

      Glioblastoma Trial in Beijing (B7-H3-targeting CAR-T cells)

      Recruiting
      • Glioblastoma
      • B7-H3-targeting CAR-T cells
      • Beijing, Beijing, China
        Beijing Tiantan Hospital
      Feb 11, 2022

      Recurrent Glioblastoma Trial in Los Angeles (biological, other, drug)

      Recruiting
      • Recurrent Glioblastoma
      • Dendritic Cell Tumor Cell Lysate Vaccine
      • +3 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Mar 29, 2022

      Recurrent Glioblastoma Trial in Shanghai (Camrelizumab plus GSC-DCV, Camrelizumab plus Placebo)

      Recruiting
      • Recurrent Glioblastoma
      • Camrelizumab plus GSC-DCV
      • Camrelizumab plus Placebo
      • Shanghai, Shanghai, China
        Huashan Hospital, Fudan University
      Nov 28, 2021

      Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

      Completed
      • Glioblastoma
      • +4 more
      • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
      • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Nov 18, 2021

      Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)

      Enrolling by invitation
      • Glioblastoma
      • +4 more
      • Seongnam, Kyunggido, Korea, Republic of
        Bundang CHA Medical Center
      Jan 6, 2022

      Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

      Completed
      Has Results
      • Glioblastoma
      • +3 more
      • Unpulsed DCs
      • +6 more
      • Durham, North Carolina
        Duke University Medical Center
      Jan 3, 2022

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023